Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001829126-25-002764
Filing Date
2025-04-17
Accepted
2025-04-17 17:00:44
Documents
7
Effectiveness Date
2025-04-17

Document Format Files

Seq Description Document Type Size
1 S-8 cyclacel_s8.htm S-8 69339
2 EXHIBIT 5.1 cyclacel_ex5-1.htm EX-5.1 13715
3 EXHIBIT 23.2 cyclacel_ex23-2.htm EX-23.2 3869
4 EXHIBIT 107 cyclacel_ex107.htm EX-FILING FEES 13029
5 GRAPHIC ex5-1_001.jpg GRAPHIC 4175
6 GRAPHIC ex23-2_001.jpg GRAPHIC 7320
7 GRAPHIC ex23-2_002.jpg GRAPHIC 2438
  Complete submission text file 0001829126-25-002764.txt   120728
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

EIN.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-286612 | Film No.: 25848140
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)